Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Single-Center, Observer-Blind, Vehicle- and Active Comparator-Controlled Phase 1b Study to Assess the Effect and Local Safety and Tolerability Of Roflumilast and BYK321084 – Phosphodiesterase Type 4 Inhibitors (PDE4i) Dermal Formulations in Patients with Chronic Plaque Psoriasis using a Psoriasis Plaque Test

Next Previous
X
Search
Trial Profile

A Randomized, Single-Center, Observer-Blind, Vehicle- and Active Comparator-Controlled Phase 1b Study to Assess the Effect and Local Safety and Tolerability Of Roflumilast and BYK321084 – Phosphodiesterase Type 4 Inhibitors (PDE4i) Dermal Formulations in Patients with Chronic Plaque Psoriasis using a Psoriasis Plaque Test

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 29 Apr 2016

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs BYK 321084 (Primary) ; Betamethasone valerate; Calcipotriol; Roflumilast
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors Takeda Pharmaceuticals International GmbH

    • Most Recent Events

    • 01 Apr 2016 Primary endpoint of change from baseline in the thickness of psoriatic skin infiltrate after 3 weeks has been met, according to results published in the British Journal of Dermatology.
    • 01 Apr 2016 Results published in the British Journal of Dermatology
    • 01 Apr 2016 Status changed from recruiting to completed, according to results published in the British Journal of Dermatology.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top